COGNITION THERAPEUTICS INCCGTXEarnings & Financial Report

Nasdaq · Health Care · Biological Products, (No Diagnostic Substances)

Deep AnalysisCompare

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical firm focused on developing innovative therapies for neurodegenerative and neuropsychiatric disorders including Alzheimer’s disease and dementia. Its core pipeline targets underlying disease mechanisms, with U.S. operations and partnerships to advance treatments for global patient populations.